TGFBR2 and Insulin resistance: An animal study suggested that the deletion of the Tgfbr2 gene in hepatocytes influences systemic insulin resistance and body weight gain in mice during the development of nonalcoholic fatty liver disease, which is the hepatic manifestation of MetS12.